nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial
|
Piccini, Jonathan P. |
|
|
199 |
C |
p. 51-58 |
artikel |
2 |
Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the means
|
Ambrosy, Andrew P. |
|
|
199 |
C |
p. 176-177 |
artikel |
3 |
Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants
|
Theodorakis, Michael J. |
|
|
199 |
C |
p. 170-175 |
artikel |
4 |
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
|
Packer, Douglas L. |
|
|
199 |
C |
p. 192-199 |
artikel |
5 |
Characteristics and long term outcomes of patients with acute coronary syndromes due to culprit left main coronary artery disease treated with percutaneous coronary intervention
|
Gharacholou, S. Michael |
|
|
199 |
C |
p. 156-162 |
artikel |
6 |
Comparison of Fractional FLow Reserve And Intravascular ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with InteRmediate Stenosis (FLAVOUR): Rationale and design of a randomized clinical trial
|
Kang, Jeehoon |
|
|
199 |
C |
p. 7-12 |
artikel |
7 |
Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery
|
Wang, Alice |
|
|
199 |
C |
p. 150-155 |
artikel |
8 |
Editorial Board
|
|
|
|
199 |
C |
p. v |
artikel |
9 |
Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction
|
Ajam, Tarek |
|
|
199 |
C |
p. 1-6 |
artikel |
10 |
Effects of a 12-week mHealth program on peak VO2 and physical activity patterns after completing cardiac rehabilitation: A randomized controlled trial
|
Duscha, Brian D. |
|
|
199 |
C |
p. 105-114 |
artikel |
11 |
IABP and cardiogenic shock: A heartbreaking story
|
Bendjelid, Karim |
|
|
199 |
C |
p. 178-180 |
artikel |
12 |
Information for Readers
|
|
|
|
199 |
C |
p. vi |
artikel |
13 |
Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial
|
Gianos, Eugenia |
|
|
199 |
C |
p. 37-43 |
artikel |
14 |
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?
|
Chan, Noel |
|
|
199 |
C |
p. 59-67 |
artikel |
15 |
Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial
|
Van Spall, Harriette G.C. |
|
|
199 |
C |
p. 75-82 |
artikel |
16 |
Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock
|
Hsu, Steven |
|
|
199 |
C |
p. 181-191 |
artikel |
17 |
Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial
|
Ambrosy, Andrew P. |
|
|
199 |
C |
p. 97-104 |
artikel |
18 |
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)
|
Capell, Warren H. |
|
|
199 |
C |
p. 83-91 |
artikel |
19 |
Rationale and design of a trial to personalize risk assessment in familial coronary artery disease
|
Marwick, Thomas H |
|
|
199 |
C |
p. 22-30 |
artikel |
20 |
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
|
Januzzi, James L. |
|
|
199 |
C |
p. 130-136 |
artikel |
21 |
Resource utilization and outcome among patients with selective versus nonselective troponin testing
|
Campbell, Alex R. |
|
|
199 |
C |
p. 68-74 |
artikel |
22 |
Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation
|
Yao, Xiaoxi |
|
|
199 |
C |
p. 137-143 |
artikel |
23 |
Shared decision-making tool for thromboprophylaxis in atrial fibrillation – A feasibility study
|
Eckman, Mark H. |
|
|
199 |
C |
p. 13-21 |
artikel |
24 |
Table of Contents
|
|
|
|
199 |
C |
p. i-iv |
artikel |
25 |
Telemedicine cardiovascular risk reduction in veterans: The CITIES trial
|
Bosworth, Hayden B. |
|
|
199 |
C |
p. 122-129 |
artikel |
26 |
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure
|
Vetrovec, George W. |
|
|
199 |
C |
p. 115-121 |
artikel |
27 |
The prognostic value of heart rate recovery in patients with coronary artery disease: A systematic review and meta-analysis
|
Lachman, Sangeeta |
|
|
199 |
C |
p. 163-169 |
artikel |
28 |
The prognostic value of the relationship between right atrial and pulmonary capillary wedge pressure in diverse cardiovascular conditions
|
Brinkley Jr., Douglas Marshall |
|
|
199 |
C |
p. 31-36 |
artikel |
29 |
Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials
|
Riaz, Haris |
|
|
199 |
C |
p. 44-50 |
artikel |
30 |
Trends and outcomes of cardiac transplantation from donors dying of drug intoxication
|
Warraich, Haider J. |
|
|
199 |
C |
p. 92-96 |
artikel |
31 |
Trends in the incidence and outcomes of patients with aortic stenosis hospitalization
|
Czarnecki, Andrew |
|
|
199 |
C |
p. 144-149 |
artikel |